~Maximum queries around Covid-care, Mental Health, Women’s Health, Pediatrics and Orthopaedics~ It has been over a year since COVID-19 proved to be a threat to mankind. It has been mercilessly challenging our healthcare system; doctors and frontline workers. The healthcare infrastructure in our country moved from
Company has kept manufacturing facilities open during Lockdown and stepped up production of essential medical devices Supply chain has been expanded 40% to support quicker deliveries and access healthcare facilities in remote parts of the country Ramped up stock of critical product codes required
Company has kept manufacturing facilities open during Lockdown and stepped up production of essential medical devices Supply chain has been expanded 40% to support quicker deliveries and access healthcare facilities in remote parts of the country Ramped up stock of critical product codes required
MGM Healthcare, a super-specialty hospital in the heart of Chennai city, today announced that it has successfully conducted an emergency endoscopic transnasal orbital surgery to treat a 68-year-old female COVID-infected patient who got seriously affected with Black fungus (Mucormycosis). The patient was being treated for COVID
Zydus, an innovation driven global pharma major and TLC, a specialty pharmaceutical company in Taiwan, today announced the signing of a license supply and commercialization agreement to commercialize AmphoTLC™ (Amphotericin B Liposome for Injection 50mg) in India. AmphoTLC™ is a critical drug to treat Mucormycosis
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high risk* of severe COVID-19 Roche India and Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced
Vaccination can mitigate COVID-19 infection for Long-Term Vaccination can mitigate COVID-19 for the long term and drive India towards being a Covid free Nation. We have become the world hub for vaccines and if we depend on the three vaccines, the estimate is that by
The situation remains critical in the country with the sudden spike in cases during the second wave. While it’s every persons wish now to get vaccinated but the supply of vaccines are limited and it may be more prudent to reset the vaccination plan to
Strengthens offerings & continues to be at the forefront of COVID care Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ‘ViraGen’ for COVID-19 in India, in partnership with Ubio Biotechnology Systems
Study shows that 97.38% of those vaccinated were protected from an infection and hospitalization rate was only 0.06% with mainly minor infections that do not lead to severe disease or hospitalization Hospital urges citizens to resist vaccine hesitancy to tide over the pandemic Indraprastha
